The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions?

Huff-Rousselle, Maggie

doi:10.1016/j.socscimed.2012.05.044

Cited by 52 publications

(62 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This follows examples in other countries, such as Canada and Western Europe, where monopsony purchase and bargaining powers have kept prices low [66]. Hospitals in Colombia carry out joint negotiations [67] and Brazil has included in its law provisions on patents and intellectual property that have helped to improve its negotiating power [68–70].…”

Section: Discussionmentioning

confidence: 99%

“…In order to assure the availability of medicines in public health care facilities in Mexico, a more comprehensive assessment of the procurement process is needed, considering the product specifications, contractual conditions of delivery, and sanctions in case of non-compliance. Suppliers invited to tender should first be pre-qualified [66] to ensure the quality of their goods and the reliability of the delivery process. It is also important to monitor the impact of the pooled procurement on the ultimate availability of medicines, in comparison to previous years, and to monitor supplier performance.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

et al. 2017

View full text Add to dashboard Cite

BackgroundThe World Health Organization recommends establishing and implementing a national pharmaceutical policy (NPP) to guarantee effective and equitable access to medicines. Mexico has implemented several policy approaches to regulate the pharmaceutical sector, but it has no formal NPP. This article describes the approach that the Mexican government has taken to improve availability and affordability of essential medicines.MethodsDescriptive policy analysis of public pharmaceutical policy proposals and health action plans on the basis of publicly available data and health progress reports, with a focus on availability and affordability of medicines.ResultsThe government has implemented pooled procurement, price negotiations, and an information platform in the public sector to improve affordability and availability. The government mainly reports on the savings that these strategies have generated in the public expenditure but their full impact on availability and affordability has not been assessed.ConclusionsTo increase availability and affordability of medicines in the public sector, the Mexican government has resorted on isolated strategies. In addition to efficient procurement, price negotiations and price information, other policy components and pricing interventions are needed. All these strategies should be included in a comprehensive NPP.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

et al. 2017

View full text Add to dashboard Cite

show abstract

“…• reduction of purchasing related costs (namely, acquisition costs (e.g., [4,12,[15][16][17]), transaction costs (e.g., [4,[16][17][18]), administrative costs (e.g., [12,17,19,20]) • human resources savings, since some purchasing effort is transferred to the group [21,17] • increased information on supply markets [18] • increased focus on core operational activities (e.g., [17,21])…”

Section: At Individual Member Level Advantagesmentioning

confidence: 99%

“…• consolidation of purchase volumes enables the negotiation of more favourable terms with suppliers [5,17,18,23] • reduction of duplicated purchasing efforts (e.g., [5]), namely, through reduction of the number of transactions (e.g., [12,18]) • development of purchasing expertise [5] • rationalised choice through better-informed selection and standardisation (e.g., [19,23])…”

Section: Disadvantagesmentioning

confidence: 99%

A hybrid approach for integrated healthcare cooperative purchasing and supply chain configuration

Rego

Claro

Sousa

2013

Health Care Manag Sci

View full text Add to dashboard Cite

This paper presents an innovative and flexible approach for recommending the number, size and composition of purchasing groups, for a set of hospitals willing to cooperate, while minimising their shared supply chain costs. This approach makes the financial impact of the various cooperation alternatives transparent to the group and the individual participants, opening way to a negotiation process concerning the allocation of the cooperation costs and gains. The approach was developed around a hybrid Variable Neighbourhood Search (VNS)/Tabu Search metaheuristic, resulting in a flexible tool that can be applied to purchasing groups with different characteristics, namely different operative and market circumstances, and to supply chains with different topologies and atypical cost characteristics. Preliminary computational results show the potential of the approach in solving a broad range of problems.

show abstract

“…Medication development will also need to expand capacity to treat the 34 million HIV patients, requiring large-scale changes to manufacturing processes [89]. Once manufacturing expands, strategies to pool purchases will be needed to reduce the cost of product purchasing [90]. Finally, the lack of accurate demand forecasting requires more accurate predictive modeling to guide the production of medications and reduce the volatility of funding cycles [91].…”

Section: Introductionmentioning

confidence: 99%

Modeling the Implementation of Universal Coverage for HIV Treatment as Prevention and its Impact on the HIV Epidemic

2014

View full text Add to dashboard Cite

The Joint United Nations Programme on HIV/AIDS (UNAIDS) recently updated its global targets for antiretroviral therapy (ART) coverage for HIV-positive persons under which 90% of HIV-positive people are tested, 90% of those are on ART, and 90% of those achieve viral suppression. Treatment policy is moving toward treating all HIV-infected persons regardless of CD4 cell count—otherwise known as treatment as prevention—in order to realize the full therapeutic and preventive benefits of ART. Mathematical models have played an important role in guiding the development of these policies by projecting long-term health impacts and cost-effectiveness. To guide future policy, new mathematical models must consider the barriers patients face in receiving and taking ART. Here, we describe the HIV care cascade and ART delivery supply chain to examine how mathematical modeling can provide insight into cost-effective strategies for scaling-up ART coverage in sub-Saharan Africa and help achieve universal ART coverage.

show abstract

The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions?

Cited by 52 publications

References 6 publications

Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

A hybrid approach for integrated healthcare cooperative purchasing and supply chain configuration

Modeling the Implementation of Universal Coverage for HIV Treatment as Prevention and its Impact on the HIV Epidemic

Contact Info

Product

Resources

About